Increased phosphate content in complement component C3, fibrinogen, vitronectin, and other plasma proteins in systemic lupus erythematosus. Covariation with platelet activation and possible association with thrombosis
Open Access
- 12 December 1997
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 40 (12) , 2178-2186
- https://doi.org/10.1002/art.1780401212
Abstract
Objective. To investigate whether extracellular phosphorylation of plasma proteins takes place in vivo in patients with systemic lupus erythematosus (SLE), to determine possible correlations between phosphate levels and clinical and/or laboratory parameters, and to identify individual phosphorylated plasma proteins. Methods. Sera from SLE patients were analyzed for total amounts of protein‐bound phosphate by a colorimetric technique, and for levels of β‐thromboglobulin by radioimmunoassay. In addition, the ability of these sera to activate platelets, resulting in the release of protein kinase, was tested using an assay in which platelet‐rich plasma from healthy blood donors was incubated with sera or immune complexes from SLE patients. In this assay, [γ‐32P]ATP was added, and 32P‐labeled C3 was quantified. Phosphate in individual proteins was detected by Western blot analysis. Results. 32P‐labeled, activated platelets were able to phosphorylate exogenously added proteins, without the addition of ATP or cations. Platelet‐rich plasma from healthy blood donors became activated by sera or by polyethylene glycol‐precipitated immune complexes from patients with SLE, which led to the extracellular phosphorylation of plasma proteins, exemplified in the C3 assay. The phosphate content in plasma proteins was increased in SLE patients with previous thrombosis. The degree of phosphorylation increased up to 3‐fold in serial samples obtained from 2 SLE patients during periods of disease exacerbation. Substantial phosphate increases were seen in C3 and fibrinogen. The changes were linked to platelet activation because of the observed covariation with the levels of β‐thromboglobulin. Conclusion. In SLE patients, the phosphate content in plasma proteins (including C3 and fibrinogen) increases due to platelet activation.Keywords
This publication has 25 references indexed in Scilit:
- Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetiiCellular Microbiology, 2007
- Purification and characterization of porcine C3. Studies of the biologically active protein and its split productsVeterinary Immunology and Immunopathology, 1992
- The response of human platelets to activated components of the complement systemImmunology Today, 1991
- The effects of in vitro phosphorylation and dephosphorylation on the thrombin-induced gelation and plasmin degradation of fibrinogenThrombosis Research, 1991
- Dephosphorylation of human fibrinogen, previously phosphorylated by protein kinase C, by whole blood or intestinal alkaline phosphatase. Effects on thrombin-induced gelation of dephosphorylated human fibrinogenThrombosis Research, 1989
- Identification of a Nonproteolytically Activated C3 with CR 1-Binding Properties in Sera from Subjects with Primary Biliary CirrhosisInternational Archives of Allergy and Immunology, 1986
- Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol groupBiochemistry, 1985
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Release reactions of human platelets induced by thrombin and other agentsBiochimica et Biophysica Acta (BBA) - General Subjects, 1968
- Amino-Acid Sequence and the Occurrence of Phosphorus in Human FibrinopeptidesNature, 1962